NORRIS MEDICINES LTD. - Submission Of Standalone Unaudited Financial Results In Compliance With Regulation 33 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended 30.06.2021<BR>

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the following:<BR> 1) Standalone Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2021.<BR> <BR> 2) Limited Review Report on Standalone Unaudited Financial Results for the quarter ended on 30th June, 2021.<BR>